Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01476111 · ClinicalTrials.gov registry record
Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer
A clinical trial, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- 117
- Enrollment target
NCT01476111 is a clinical trial that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 117 participants.
The verdict
NCT01476111 was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- 117 participants
- Enrollment target
Study Summary
This study will examine specific biomarkers in primary invasive breast cancer and explore their correlation with patient outcome following standard neoadjuvant treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01476111
The ClinicalTrials.gov registry entry for NCT01476111 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01476111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01476111 about?
NCT01476111 is a clinical study titled "Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer". This study will examine specific biomarkers in primary invasive breast cancer and explore their correlation with patient outcome following standard neoadjuvant treatment.
What is the current status of trial NCT01476111?
This trial is currently terminated. The enrollment target is 117 participants. The study started on 2011-12. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT01476111?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.